Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. ILC 2018: NGM’s intravenous NASH therapy shows rapid reduction in liver fat content and fibrosis
  2. CD40 agonist developments could support Anti-PD-(L)1 therapy in pancreatic cancer
  3. ILC 2018: Allergan’s cenicriviroc shows continued fibrosis response in NASH patients in two year extended study
  4. Oral pill to treat psoriasis: could this be a game-changer?
  5. Stem cell therapies could reduce effects of stroke-related disability

Latest Content

Novartis reports positive outcome in LIBERTY trial

Novartis has reported positive results in the LIBERTY trial, a Phase IIIb study investigating the safety and efficacy of Aimovig (erenumab) in patients with episodic migraine who had previously failed two to four preventive treatments for migraine.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top